A meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.
|Articles|April 8, 2019
Impact of California's vaccine exemption bill (VIDEO)
Author(s)Bobby Lazzara, MD
Advertisement
For Contemporary Pediatrics, Dr Bobby Lazzara discusses a study in Pediatrics that looked at what occurred in the wake of California's Senate Bill 277, which removed personal belief exemptions for vaccines.
Advertisement
Related to this article
New real-world data reveal delays and disparities in nirsevimab administration, highlighting opportunities to improve timely RSV protection for infants.
CDC confirmed the first pediatric flu death of 2026-27, linked to H1N1, as early flu activity rises in 2026.
With California WNV activity at a 5-year high, CHLA outlines age-based repellent and bite-prevention guidance for children.
Johanna Chang, MD, offers guidance on vaccination, infection prophylaxis, and clinical warning signs in children receiving biologic therapies.
Completing the DTaP primary series was 96.2% effective against pertussis in Alaska children aged 6 months to 6 years during a record 2024 outbreak.
Todd Wolynn, MD, MMM, FAAP, explains how pediatricians can address misinformation through empathetic communication and community engagement.
Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Skipping newborn vitamin K tied to 47% higher infant bleeding risk
2
Breastfeeding essentials: Assessing latch and milk transfer
3
Contemporary Pediatrics week in review: November 2-6, 2026
4
Maternal RSVpreF 78% effective against infant RSV hospitalization
5